Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Sugammadex as Rescue Therapy Following Inadequate Reversal With Neostigmine

NCT05661409 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05661409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05661409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Sugammadex as Rescue Therapy Following Inadequate Reversal With Neostigmine
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
July 21, 2023
Completion date
August 2, 2024
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blockade